SCHEDULE: Ching Choon Hwa Discloses 8.45% Stake in China SXT

Ching Choon Hwa has reported beneficial ownership of 8.45% of China SXT Pharmaceuticals, Inc.'s Ordinary Shares.

Summary

• Ching Choon Hwa, a Singapore citizen, has filed a Schedule 13G indicating beneficial ownership in China SXT Pharmaceuticals, Inc.
• The filing reports sole voting power over 9,803,920 Ordinary Shares.
• Ching Choon Hwa also holds sole dispositive power over 9,803,920 Ordinary Shares.
• The aggregate amount beneficially owned is 9,803,920 Ordinary Shares.
• This ownership represents 8.45% of the total class of Ordinary Shares outstanding.
• The percentage is calculated based on 116,027,758 Ordinary Shares outstanding as of July 29, 2025.
• The total voting power of the Issuer is 116,053,826 votes, with Class A Ordinary Shares having one vote and Class B Ordinary Shares having fifty votes.
• The Reporting Person's 9,803,920 Class A Ordinary Shares represent approximately 8.45% of the Issuer's total voting power.
• The securities were not acquired for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would inherently convey positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of beneficial ownership and does not provide specific industry context or competitive analysis. It indicates a significant individual stake in a pharmaceutical company.

Stakeholder Impact

• Shareholders: The disclosure of a significant individual stake (8.45%) may be viewed positively by some investors as a sign of confidence, or it could signal potential future changes in ownership structure or influence.

Key Dates

Keywords

China SXT Pharmaceuticals, Schedule 13G, Beneficial Ownership, Shareholder, Equity Stake, Pharmaceuticals, SEC Filing, G2161P157